What is FEMY's current stock price?

FEMY (Femasys Inc.) is currently trading at $0.44 with a market cap of $12.9M.

What sector is Femasys Inc. in?

Femasys Inc. (FEMY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.

InvestLog

FEMY Femasys Inc.

Healthcare

$0.44+29.85%ClosedMarket Cap: $12.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

4.00

P/S

5.43

EV/EBITDA

-0.83

DCF Value

$-0.52

FCF Yield

-144.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

53.1%

Operating Margin

-687.9%

Net Margin

-521.8%

ROE

-258.1%

ROA

-75.2%

ROIC

-118.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$424.9K	$328.6K	$—
Q4 null	$813.4K	$-4.0M	$—
FY null	$2.3M	$-18.6M	$—
Q3 null	$729.4K	$-4.2M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2025-08-11

HC Wainwright & Co.Buy

2025-06-25

Trading Activity

Insider Trades

View All

Canning John Charlesofficer: Chief Operating Officer

SellWed Apr 01

Canning John Charlesofficer: Chief Operating Officer

SellWed Apr 01

Lee-Sepsick Kathydirector, officer: Chief Executive Officer

SellFri Mar 27

Larsen Charlesdirector

SellFri Mar 27

Elefant Dovofficer: Chief Financial Officer

SellFri Mar 27

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

Exchange

—

Beta

-2.25

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Peers